1. Rizzetto, M., Pourcell, R., Gerin, J. Epidemiology of HBV associated delta agent: geographical distribution of anti-delta and prevalence of polytransfused HBsAg carriers. Lancet i (1983) 1215–1217.
2. De Virgiliis, S., Fiorelli, G., Fargion, S., Cornacchia, G., Sanna, G., Murgia, V., Cao, A. Chronic liver disease in transfusion dependent thalassaemia: hepatitis B virus marker studies. J. Clin. Pathol. 33 (1980) 949–953.
3. Papaevangelou, G., Frösner, G., MconomiDiou, J., Parcha, S., Roumeliotou, A. Prevalence of hepatitis A and B infection in multiply transfused thalassaemic patients. Br. Med. J. 1 (1978) 689–693.
4. Sciacca, A., Di Gregorio, F., Romeo, M., Zisa, S., Musimeci, S. Primi risultati della vaccinazione anti-HBV in bambini talassemici siciliani. Gior. Mal. Infet. Parass. 38 (1986) 45–47.
5. De Martino, M., Rossi, M., Resti, M., Appendino, C., Mannelli, F., Di Palma, A., Borgatti, L., Vierucci, A. Hepatitis B vaccine immunization of multitransfused β-thalassaemia children at high risk from hepatitis B virus infection. Immunotherapy 1 (1985) 177–179.